Work to develop a new formulation of a common metabolic inhibitor (niclosamide) by David Needham, Professor of Translational Therapeutics in the School of Pharmacy at the University of Nottingham and Professor of Mechanical Engineering and Materials Science at Duke University, could result in a promising early treatment for Covid-19. Click to read more.
It is now a little over four hundred years since a scattering of Westerners first began to try to learn the Chinese language. Across that long span, the number of scholars studying Chinese has grown, but their responses to the challenges of Chinese script have been generally consistent. Most have just slogged away, with reasonable success, and treated the task as an